The independent source for health policy research, polling, and news.
Despite the usual view that physicians are slow to alter their routines based on new scientific evidence, researchers found that breast cancer surgeons quickly adopted advice to not remove lymph nodes after a landmark clinical trial in 2011.
Some say this trend is the future of biomedical research. But along with its potential, it also faces significant challenges.
The decision runs counter to a Senate committee that voted to strip the $52 million appropriation for the State Health Insurance Assistance Program, which helps beneficiaries understand their Medicare coverage and helps them with billing issues.
The state’s Medicaid program quit covering the expensive therapy, called applied behavioral analysis, leaving some families scrambling to afford the treatment.
Patrick Kennedy, a former congressman from Rhode Island, and Newt Gingrich, who was once the House speaker, are advancing policies to combat this national crisis.
A new health benefit available to millions of Californians encourages people to discuss end-of-life care options with their doctors.
A Health Affairs study determines that Part D spending went down slightly on prescription drugs for which medical marijuana is viewed as a possible alternative.
A study in Health Affairs finds Medicare Part D beneficiaries were charged copays averaging 10.5 times more for Crestor and Nexium than generic drugs would have cost them.
Researchers examined shoppers’ reviews of sunscreen products on Amazon.com and found that their the ratings often were based on scent, texture and performance, but didn’t necessarily take into account whether the products were consistent with dermatologists’ recommendations.
Public health officials are wrestling with how to safeguard and maintain blood bank reserves in the face of concerns that the Zika virus can be spread through transfusions.
A new study shows that Sacramento and San Francisco are the two most expensive places to give birth among the nation’s 30 largest metropolitan areas. One possible reason: consolidation of hospitals and doctors.
Garen Wintemute, an ER doctor, gun violence researcher and advocate of tighter firearms restrictions, finds opportunity in the wake of mass shootings like the one that struck an Orlando night club last month.
Over the past few months, Massachusetts, Florida, New York, Delaware and Washington have lifted restrictions on the expensive medications, and private insurers around the country are also making the changes.
Even as the administration focuses on getting more young adults into marketplace coverage, many enrollment specialists say that this group has some difficulty transitioning from family plans or Medicaid.
Treatments marketed as everything from anti-aging applications to therapies for degenerative diseases are increasingly available at commercial clinics in the U.S., but their growing numbers raise ethical and regulatory concerns in the scientific community.
It was a big win for pro-abortion rights advocates, but abortion opponents are not daunted. Stay tuned for how it will affect presidential politics and the next generation of women voters.
The case alleges that insured consumers were overcharged because of a contract agreement.
Urban Institute researchers examine how such a plan could work and whether it would be better to make payments when people first need care or after they have used up much of their own money instead.
The lawsuits allege that the practice costs the hospitals money because the patients often spend the funds.
Health experts remain divided on legalizing marijuana for recreational use.
